# Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)

> **NCT02074007** · PHASE3 · TERMINATED · sponsor: **Arbor Pharmaceuticals, Inc.** · enrollment: 178 (actual)

## Conditions studied

- Acute Otitis Media

## Interventions

- **DRUG:** AR01
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT02074007
- **Lead sponsor:** Arbor Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 178 (ACTUAL)
- **Why stopped:** primary outcome measure not met
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02074007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02074007, "Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02074007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*